advertisement
Advertisement (image not found)

Pharmaceutical News

Page
12345›»

FDA Announces New Boxed Warning On Plavix

Alerts patients, health care professionals to potential for reduced effectiveness

Friday, March 12, 2010 Source: U.S. Food and Drug Administration

Neoprobe Says Radioactive Tracing Agent's NDA On Track

Diagnostics products maker Neoprobe Corp said U.S. health regulators have indicated...

Friday, March 12, 2010 Source: Reuters

U.S. Safety Panel Says Big Vytorin Study Can Go On

Merck & Co on Thursday said an independent data safety monitoring board has...

Friday, March 12, 2010 Source: Reuters

FDA Approves Five-Day Dosing Regimen For Dacogen® (decitabine) For Injection, Offering A New Outpatient Dosing Option For Myelodysplastic Syndromes (MDS)

Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA)...

Thursday, March 11, 2010 Source: Eisai Inc.

FDA Approves Watson's TRELSTAR® 22.5 Mg, The First And Only 6-Month Intramuscular GnRH Agonist For The Palliative Treatment Of Advanced Prostate Cancer

Watson Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration...

Thursday, March 11, 2010 Source: Watson Pharmaceuticals, Inc.

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin®

Caraco Pharmaceutical Laboratories, Ltd. has launched oxaliplatin injections...

Thursday, March 11, 2010 Source: Caraco Pharmaceutical Laboratories, Ltd.

CEL-SCI Receives Payment From Marketing Partner

CEL-SCI Corporation announced today that it has received a $125,000 payment...

Wednesday, March 10, 2010 Source: CEL-SCI Corporation

Watson Pharmaceuticals, Inc. (WPI), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Resolve Actos Patent Litigation

Watson Pharmaceuticals, Inc. (NYSE:WPI - News), today announced that it has...

Wednesday, March 10, 2010 Source: PRNewswire

FDA Approves Botox To Treat Spasticity In Flexor Muscles Of The Elbow, Wrist And Fingers

The U.S. Food and Drug Administration today approved Botox (onabotulinumtoxin...

Tuesday, March 09, 2010 Source: U.S. Food and Drug Administration

AstraZeneca's Recentin Fails Trial, Hurts Shares

Avastin in colorectal cancer patients, hurting the Anglo-Swedish drugmaker's shares on Monday.

Tuesday, March 09, 2010 Source: Reuters
Page
12345›»

News Search

Search News By Keywords

News Sections

New Technologies

Cypridina Luciferase Expression Vectors and Assay Reagents
Cypridina Luciferase Expression...
from Targeting Systems
More New Technologies
advertisement
Advertisement (image not found)

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)






 Select All

Privacy Policy | Manage Subscriptions

Loading

Loading